Company intelligence / Profile preview

American Bionostica

Swedesboro, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

American Bionostica is a commercial developer and manufacturer of rapid quantitative lateral flow immunochromatographic tests used across health care, biotechnology, veterinary, food, environmental and related diagnostics markets; it does not develop therapeutic drugs or run clinical trials[1][2][3][9][10].

Modalities: DeviceNon-pharmacological therapy
Industry: Protein Biomarker Diagnostics

Partnerships

Multiple OEM/contract development and manufacturing partnerships with diagnostic companies of various sizes, including large multinational corporations (described generally, specific partner names not disclosed)[5][9][10].

Beyond the preview

Go deeper on American Bionostica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American Bionostica.

Explore the full profile